Vor Biopharma Inc. (VOR) SEC Filings — 2025

Filings

• Vor Biopharma Files 8-K: Agreements, Equity Sales, Officer Changes — 8-K · Dec 18, 2025
• Vor Biopharma Inc. 8-K Filing — 8-K · Dec 9, 2025
• Vor Biopharma's Net Loss Explodes to $2.4B on Warrant Liabilities — 10-Q · Nov 13, 2025
• Vor Biopharma Files 8-K — 8-K · Nov 12, 2025
• Vor Biopharma Announces Board and Executive Changes — 8-K · Nov 3, 2025
• Vor Biopharma Files 8-K for Disclosures — 8-K · Oct 28, 2025
• Vor Biopharma Files 8-K: Rights Modifications & Other Events — 8-K · Sep 17, 2025
• Vor Biopharma Files 8-K: Regulation FD & Financials — 8-K · Sep 2, 2025
• Vor Biopharma Reports Director Changes and Officer Appointments — 8-K · Aug 27, 2025
• Vor Biopharma's Q2 Loss Explodes to $1.6B on Warrant Liabilities, R&D Surge — 10-Q · Aug 12, 2025
• Vor Bio Seeks Reverse Split, Boosts Equity Plan Shares — DEF 14A · Aug 8, 2025
• Vor Biopharma Appoints New Director, Discloses Officer Compensation — 8-K · Jul 22, 2025
• Vor Biopharma Inc. Reports Board and Compensation Changes — 8-K · Jul 10, 2025
• Vor Biopharma Inc. Files 8-K: Agreements, Equity Sales, Officer Changes — 8-K · Jun 26, 2025
• Vor Biopharma Files 8-K with Corporate Updates — 8-K · May 23, 2025
• Vor Biopharma Inc. Announces Board and Executive Changes — 8-K · May 20, 2025
• Vor Biopharma Files Q1 2025 10-Q — 10-Q · May 14, 2025
• Vor Biopharma Files 8-K: Executive Changes & Restructuring — 8-K · May 8, 2025
• Vor Biopharma Faces Nasdaq Delisting — 8-K · Apr 25, 2025
• Vor Biopharma Files Definitive Proxy Statement — DEF 14A · Apr 8, 2025
• Vor Biopharma Reports Director/Officer Changes — 8-K · Apr 3, 2025
• Vor Biopharma Files 2024 10-K — 10-K · Mar 20, 2025
• Vor Biopharma Announces Board and Officer Changes — 8-K · Feb 6, 2025
• Vor Biopharma Announces Board and Compensation Changes — 8-K · Jan 8, 2025